CN1126437A - 细胞的制备和稳定化 - Google Patents

细胞的制备和稳定化 Download PDF

Info

Publication number
CN1126437A
CN1126437A CN 94192671 CN94192671A CN1126437A CN 1126437 A CN1126437 A CN 1126437A CN 94192671 CN94192671 CN 94192671 CN 94192671 A CN94192671 A CN 94192671A CN 1126437 A CN1126437 A CN 1126437A
Authority
CN
China
Prior art keywords
feature
preparation
arbitrary
stabilizing agent
whole blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 94192671
Other languages
English (en)
Chinese (zh)
Inventor
V·格兰杰
D·巴尼特
J·T·赖利
P·S·M·迈尔
S·P·费伊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Northern General Hospital NHS Trust
Original Assignee
Northern General Hospital NHS Trust
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939313962A external-priority patent/GB9313962D0/en
Priority claimed from GB9406698A external-priority patent/GB9406698D0/en
Application filed by Northern General Hospital NHS Trust filed Critical Northern General Hospital NHS Trust
Publication of CN1126437A publication Critical patent/CN1126437A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2496/00—Reference solutions for assays of biological material
    • G01N2496/05—Reference solutions for assays of biological material containing blood cells or plasma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Ecology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN 94192671 1993-07-05 1994-07-05 细胞的制备和稳定化 Pending CN1126437A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9313962.4 1993-07-05
GB939313962A GB9313962D0 (en) 1993-07-05 1993-07-05 Preparation and stabilisation of leucocytes
GB9315871.5 1993-07-20
GB9406698.2 1994-04-05
GB9406698A GB9406698D0 (en) 1994-04-05 1994-04-05 Preparation and stabilisation of cell suspensions

Publications (1)

Publication Number Publication Date
CN1126437A true CN1126437A (zh) 1996-07-10

Family

ID=26303195

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 94192671 Pending CN1126437A (zh) 1993-07-05 1994-07-05 细胞的制备和稳定化

Country Status (2)

Country Link
EP (1) EP0721104A2 (cg-RX-API-DMAC10.html)
CN (1) CN1126437A (cg-RX-API-DMAC10.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8029978B2 (en) 2005-02-25 2011-10-04 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Processing method for the long-term stabilization of biological red blood cell volume
CN104178424A (zh) * 2013-05-24 2014-12-03 益善生物技术股份有限公司 一种红细胞裂解液及其裂解方法

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018136751A1 (en) * 2017-01-22 2018-07-26 Chryos, Llc Composition and method of use of the same for preserving cells for analysis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2551208C3 (de) * 1975-11-14 1981-05-27 Behringwerke Ag, 3550 Marburg Verfahren zur Herstellung einer stabilen Erythrozyten-Präparation
DE2828820A1 (de) * 1977-08-01 1979-02-08 Warner Lambert Co Verfahren zur herstellung einer stabilen blutplaettchensuspension und nach dem verfahren erhaltene stabile blutplaettchensuspension
US4346018A (en) * 1980-06-16 1982-08-24 Coulter Electronics, Inc. Multi-purpose blood diluent and lysing agent for differential determination of lymphoid-myeloid population of leukocytes
US4405719A (en) * 1981-05-29 1983-09-20 Coulter Electronics, Inc. Method of stabilizing platelets for determining multiple platelet parameters in reference control and calibrator compositions; diluents therefor; and combination stabilization procedures
US4704352A (en) * 1985-06-25 1987-11-03 Baxter Travenol Laboratories, Inc. L-ascorbate-2-phosphate salts in blood cell storage
US4675185A (en) * 1985-12-06 1987-06-23 Baxter Travenol Laboratories, Inc. Solution for stabilizing red blood cells during storage

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8029978B2 (en) 2005-02-25 2011-10-04 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Processing method for the long-term stabilization of biological red blood cell volume
CN104178424A (zh) * 2013-05-24 2014-12-03 益善生物技术股份有限公司 一种红细胞裂解液及其裂解方法

Also Published As

Publication number Publication date
EP0721104A2 (en) 1996-07-10
EP0721104A3 (cg-RX-API-DMAC10.html) 1996-08-14

Similar Documents

Publication Publication Date Title
CN1149338A (zh) 细胞悬浮液的制备和稳定化
EP0708649B1 (en) Preparation and stabilisation of cells
Van den Bossche et al. Alternatively activated macrophages engage in homotypic and heterotypic interactions through IL-4 and polyamine-induced E-cadherin/catenin complexes
Kim et al. Functional selectivity in cytokine signaling revealed through a pathogenic EPO mutation
CN1154848C (zh) 用于血红蛋白和细胞分析的无氰化物裂解试剂组合物与方法
CN1088194C (zh) 测定幼稚细胞用试剂
CN1153972C (zh) 用于血红蛋白和细胞分析的组合物与方法
CN1747729A (zh) Janus酪氨酸激酶3(JAK3)的选择性抑制方法
CN103336110B (zh) 一种全血质控物及其制备方法
Basso‐Ricci et al. Multiparametric whole blood dissection: a one‐shot comprehensive picture of the human hematopoietic system
CN101074962A (zh) Abo血型反定型试剂
EP3264083B1 (en) L-fabp immunoassay method
CN1126437A (zh) 细胞的制备和稳定化
EP3535589B1 (fr) Procédé de determination de la teneur en hémoglobine f d'une cellule érythroïde
CN112504793A (zh) 用于渗透和固定血细胞的试剂及分析方法
CN1924583A (zh) Abo血型反定型试剂
Balding et al. Response of human lymphocytes to PHA and tumour-associated antigens as detected by fluorescence polarization
US20240151708A1 (en) Assay
CN1237346C (zh) 人髓质素的免疫测定方法以及用该方法诊断多发性硬化
Pivetta et al. Functional osteoclastogenesis: The baseline variability in blood donor precursors is not associated with age and gender
Yu et al. Trying to Kill a Killer; Impressive Killing of Patient Derived Glioblastoma Cultures Using NK-92 Natural Killer Cells Reveals Both Sensitive and Highly Resistant Glioblastoma Cells
CN115078739A (zh) 一种检测载脂蛋白a1的试剂盒及其应用
Shichishima et al. Low concentration of serum haptoglobin has impact on understanding complex pathophysiology in patients with acquired bone marrow failure syndromes
Thiele et al. Clinical and research methods for analysis and study of platelet populations
KR102261148B1 (ko) ABO 및 RhD 혈액형 표현형이 약화된 시험관법 혈액형 검사의 정도관리용 글루타르알데히드 처리 적혈구 생산방법

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication